Document Detail


Acute effects of alpha-1 adrenoceptor antagonist, doxazosin on circulating vasoactive hormones.
MedLine Citation:
PMID:  7480965     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The acute effects of doxazosin, a new selective alpha-1 adrenergic blocking agent, on blood pressure, heart rate, and on some circulating vasoactive hormones, such as plasma renin activity, catecholamines, serotonin and endothelin-1 in ten healthy normotensive volunteers and eight moderate-severe essential hypertensives were studied. Two milligrams doxazosin was administered orally in randomised fashion as compared to placebo and the acute effects were evaluated one half to four hours later. Doxazosin did not reduce blood pressure and did not increase heart rate in normotensive subjects as compared to placebo. A significant decrease in blood pressure was found in hypertensives after doxazosin (p < 0.01), without change in heart rate. Simultaneously, doxazosin did not modify plasma renin activity, catecholamines, serotonin and endothelin-1 concentrations both in normotensive and hypertensive subjects when compared with placebo administration. Thus, it appears that doxazosin does not influence local and systemic vasopressor hormones involving in the regulation of blood pressure. In conclusion, the lack of effects on plasma vasoactive factors confirms the selective alpha-1 postsynaptic antagonism of doxazosin and an effective antihypertensive action in the treatment of essential hypertension.
Authors:
F Veglio; D Schiavone; A Rossi; L Chiandussi
Related Documents :
20511125 - Effect of angiotensin ii type 1 receptor blocker, candesartan, and beta 1 adrenoceptor ...
1260965 - Reflex suppression of renin secretion during distention of cardiopulmonary receptors in...
394935 - Correlations of the fibrinogen level with the blood pressure and with the plasma renin ...
17693755 - Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor bloc...
20136475 - Qualitative study of principles pertaining to lifestyle and pressure ulcer risk in adul...
10388905 - Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive pat...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue européenne pour les sciences médicales et pharmacologiques     Volume:  16     ISSN:  0392-291X     ISO Abbreviation:  Riv Eur Sci Med Farmacol     Publication Date:    1994 May-Aug
Date Detail:
Created Date:  1995-11-29     Completed Date:  1995-11-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8100897     Medline TA:  Riv Eur Sci Med Farmacol     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  85-90     Citation Subset:  IM    
Affiliation:
Dipartimento di Medicina e Oncologia Sperimentale, University of Turin, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Antagonists / pharmacology*
Adult
Double-Blind Method
Doxazosin / pharmacology*
Female
Hormones / blood*
Humans
Hypertension / physiopathology
Male
Middle Aged
Receptors, Adrenergic, alpha-1 / antagonists & inhibitors*
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Antagonists; 0/Hormones; 0/Receptors, Adrenergic, alpha-1; 74191-85-8/Doxazosin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reinfusion ascites therapy: considerations after a year's experience
Next Document:  A new dry chemistry immunoassay: comparison with a fluorescence polarization system.